We then assessed the associations of CXCL9, CXCL10, and CXCL11, that were different between groups, with clinical characteristics, diagnosis, and treatment responsiveness to identify biomarkers of inflammation in ILD with background autoimmunity. This evidence concerns the gene CXCL10 and interstitial lung disease.